Teladoc Health’s revenue is declining as BetterHelp struggles, causing the stock to plummet 98% from its high. Management is working on repositioning the business, aiming to improve its value proposition. Despite a low stock price, risks remain. Revenue in the third quarter of 2025 dropped 2% to $626 million. Segment performance shows integrated care revenue rose 2%, but BetterHelp revenue fell 8%. Teladoc’s U.S. integrated care membership grew 9% to 102.5 million. BetterHelp is transitioning to insurance acceptance from cash-paying customers. Key metrics for BetterHelp are improving, but challenges persist. Teladoc trades at 0.5 times sales, generating cash flow but posting a net loss. Fourth-quarter revenue guidance is weak, signaling ongoing struggles. The company is still working to find a sustainable model for growth. Teladoc Health is not on the list of 10 best stocks to buy, indicating continued challenges. The Motley Fool Stock Advisor team advises caution with Teladoc Health, citing its struggles in creating shareholder value.

Read more at Yahoo Finance: Down 98% From Its All-Time High? Is It Finally Time to Buy This Former Market Darling?